Galectin signatures contribute to the heterogeneity of breast cancer and provide new prognostic information and therapeutic targets.
about
Galectin-1 knockdown improves drug sensitivity of breast cancer by reducing P-glycoprotein expression through inhibiting the Raf-1/AP-1 signaling pathwayDetection of IKKε by immunohistochemistry in primary breast cancer: association with EGFR expression and absence of lymph node metastasis.Galectin-7 Expression Potentiates HER-2-Positive Phenotype in Breast Cancer.A review of the importance of immune responses in luminal B breast cancer.Tissue and plasma levels of galectins in patients with high grade serous ovarian carcinoma as new predictive biomarkersIntracellular galectin-7 expression in cancer cells results from an autocrine transcriptional mechanism and endocytosis of extracellular galectin-7.Immune Checkpoint Molecules on Tumor-Infiltrating Lymphocytes and Their Association with Tertiary Lymphoid Structures in Human Breast Cancer.Overall Survival of Ovarian Cancer Patients Is Determined by Expression of Galectins-8 and -9.The emerging role of galectins in high-fatality cancers.Galectin-9 Expression Predicts Favorable Clinical Outcome in Solid Tumors: A Systematic Review and Meta-Analysis.
P2860
Q33648764-F1160FE3-A8F7-40B6-9635-1750F044DE8BQ33717414-04BE15D9-3C2C-4AED-A3A4-6DFE459D775DQ36208118-8540BE1E-1443-4A2C-987C-595880223DE2Q39239484-F0966624-EBA0-4A76-BE74-2411695CF8F9Q42378844-6ECA4FE1-9E54-4EA1-8B60-07A5057C949AQ43921368-8641E269-096B-433C-9653-EAF67068377AQ47109363-C0B553D6-3AC9-4038-B60D-CCED8896CF78Q48182229-FBFF4CC6-44CC-43E7-BB01-4BF46B52F46EQ50101341-919C9A4E-57A6-4143-9132-1BF28E08681EQ54968635-60074A3A-B6DA-4FC5-800A-3F80E02361F5
P2860
Galectin signatures contribute to the heterogeneity of breast cancer and provide new prognostic information and therapeutic targets.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 27 February 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Galectin signatures contribute ...... ation and therapeutic targets.
@en
Galectin signatures contribute ...... ation and therapeutic targets.
@nl
type
label
Galectin signatures contribute ...... ation and therapeutic targets.
@en
Galectin signatures contribute ...... ation and therapeutic targets.
@nl
prefLabel
Galectin signatures contribute ...... ation and therapeutic targets.
@en
Galectin signatures contribute ...... ation and therapeutic targets.
@nl
P2093
P2860
P356
P1433
P1476
Galectin signatures contribute ...... ation and therapeutic targets.
@en
P2093
Andrée-Anne Grosset
Einas M Yousef
Louis Gaboury
Maria Claudia Vladoiu
Yves St-Pierre
P2860
P304
18183-18203
P356
10.18632/ONCOTARGET.7784
P407
P577
2016-02-27T00:00:00Z